g Primary ciliary dyskinesia (PCD) is a genetic disease characterized by abnormalities in ciliary function, leading to compromised airway clearance and chronic bacterial infection of the upper and lower airways. The compositions of these infections and the relationships between their characteristics and disease presentation are poorly defined. We describe here the first systematic culture-independent evaluation of lower airway bacteriology in PCD. Thirty-three airway samples (26 from sputum, 7 from bronchoalveolar lavage [BAL] fluid) were collected from 24 PCD patients aged 4 to 73 years. 16S rRNA quantitative PCR and pyrosequencing were used to determine the bacterial loads and community compositions of the samples. Bacterial loads, which ranged from 1.3 ؋ 10 4 to 5.2 ؋ 10 9 CFU/ml, were positively correlated with age (P ‫؍‬ 0.002) but not lung function. An analysis of ϳ7,000 16S rRNA sequences per sample identified bacterial species belonging to 128 genera. The concurrently collected paired samples showed high bacterial community similarity. The mean relative abundance of the dominant genera was 64.5% (standard deviation [SD], 24.5), including taxa reported through standard diagnostic microbiology (members of the genera Pseudomonas, Haemophilus, and Streptococcus) and those requiring specific ex vivo growth conditions (members of the genera Prevotella and Porphyromonas). The significant correlations observed included a positive relationship between Pseudomonas aeruginosa relative abundance and age and a negative relationship between P. aeruginosa relative abundance and lung function. Members of the genus Ralstonia were also found to contribute substantially to the bacterial communities in a number of patients. Follow-up samples from a subset of patients revealed high levels of bacterial community temporal stability. The detailed microbiological characterization presented here provides a basis for the reassessment of the clinical management of PCD airway infections.
P
rimary ciliary dyskinesia (PCD) is a genetic disease characterized by abnormal ciliary structure and function. While variations in diagnostic approaches make PCD prevalence difficult to determine accurately, the reported incidence rates range from 1 in 2,000 to 1 in 40,000 (1) .
Abnormal ciliary function leads to impaired mucociliary clearance, chronic airway infection and inflammation, bronchiectasis, and chronic otitis media (2) . The consequence is airway stasis, which is a unique characteristic of PCD compared with those of other chronic lung diseases. In addition, the vast majority of patients with PCD have low nasal nitric oxide (nNO) levels, which have a potential impact on innate immunity (3) . Chronic productive cough and nasal congestion are almost universal, with chronic bronchitis, recurrent pneumonia, and bronchiectasis also being common in PCD patients. Lung disease in PCD begins early in childhood, with considerable variation in the progression and severity between individuals (1, 4) . Situs inversus is present in approximately half of patients (4) .
While chronic infections of the PCD airways are strongly associated with morbidity and mortality (5) , relatively little is known about their bacterial composition. An observational culture-based study from the United States reported nontypeable Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, and oropharyngeal species to be most frequently isolated from children and adolescents, with Pseudomonas aeruginosa and nontuberculous mycobacteria being more common in adults and patients with advanced lung disease (6) . However, the extent to which these findings are representative of PCD patients more widely, and the prevalence of species that are refractory to growth under conditions that are used in standard diagnostic microbiology, are not known.
Culture-independent analytical techniques, including nextgeneration sequencing, have allowed for the detailed characterization of lower airway bacterial communities associated with a range of obstructive airway diseases. Such analyses have typically revealed much greater bacterial diversity than is reported through standard diagnostic microbiology (7) (8) (9) (10) (11) (12) , with a substantial contribution often made by species requiring anaerobic conditions for growth, including members of the genera Prevotella, Veillonella, Propionibacterium, and Actinomyces (8, 13) .
In most cases, evidence of a direct pathogenic role in lower airway infections for any single species remains to be demonstrated. However, in cystic fibrosis (CF) (10, (14) (15) (16) and non-CF bronchiectasis (17) , the characteristics of the bacterial community as a whole, such as the number of bacterial species present (richness) or their relative abundance (evenness), have been correlated with clinical measures of disease severity and progression. Whether similar bacterial communities develop in PCD airways as a result of impaired clearance has not been reported previously. Obtaining a comprehensive and detailed characterization of PCD lower airway bacteriology is therefore important, both to identify the species that might contribute directly to airway disease and to determine the potential markers of disease progression. Our aim was to perform the first systematic evaluation of lower airway bacteriology in PCD. In keeping with other conditions where airway clearance is compromised, we hypothesized that a culture-independent analysis of PCD respiratory samples would reveal a greater bacterial diversity than that reported through diagnostic microbiology, and further, that the composition of this airway microbiota would correlate with clinical measures of disease.
MATERIALS AND METHODS
Twenty-four patients were recruited from the adult and pediatric PCD clinics at University Hospital Southampton. All had been diagnosed with PCD by the national PCD service according to international diagnostic guidelines (4, 18) . Written informed consent was provided by patients or parents (local and national research and development [R&D] and ethical approvals CHI395 and 07/Q1702/109). The study population data are summarized in Table 1 and the details, including those of the follow-up samples, shown in Table S1 in the supplemental material. Ciliary abnormalities and cases of situs inversus are detailed in Table S2 in the supplemental material.
Twenty-six spontaneously expectorated sputum samples were collected between July 2012 and February 2013 during routine appointments (if stable) or during exacerbations. Exacerbations were defined as a change in respiratory symptoms that the PCD specialist considered to be caused by a lower respiratory tract infection requiring antibiotic therapy. In addition, 7 bronchoalveolar lavage (BAL) fluid samples had been collected from 5 PCD patients between 2002 and 2010. The sputum and BAL fluid samples for molecular analysis were transferred to the laboratory on ice and stored at Ϫ80°C.
Standard diagnostic microbiology was performed on sample aliquots at the Health Protection Agency South East Laboratory, in accordance with standard protocols. Bacteria were pelleted from the BAL fluid samples by centrifugation, and the sputa and BAL fluid pellets were transported to King's College London for molecular analysis.
Molecular analysis of bacterial community composition. DNA extractions were performed as described previously (17) . An estimation of bacterial cell numbers per unit volume of respiratory samples was achieved by quantitative PCR (qPCR) as described previously (10) . Amplicon pyrosequencing (bacterial tag-encoded FLX amplicon pyrosequencing [bTEFAP]) was also performed as described previously (19) . The detailed protocols for all analytical steps are provided in the supplemental material. Statistical analysis was performed using a variety of computer packages, including XLStat, NCSS 2007, R, and NCSS 2010. Alpha and beta diversity analyses were conducted as described previously (19) (20) (21) (22) . Unless otherwise confirmed by species-specific PCR, the detected bacteria are reported at the genus level.
A genus-specific PCR assay for Ralstonia was used as described previously (23) . Specific PCR assays for Ralstonia respiraculi, Ralstonia insidiosa, Ralstonia pickettii, and Ralstonia mannitolilytica were performed as described previously (23, 24) . P. aeruginosa-specific PCR was performed as described previously (25) and used to confirm the identifications achieved through pyrosequencing. The primer details are given in Table  S3 in the supplemental material, and the reaction conditions are provided in the supplemental material.
RESULTS AND DISCUSSION
By performing the first systematic assessment of PCD airway microbiota, our aim was to examine the extent to which relationships exist between the features of airway bacterial community composition and clinical measures of disease. Further, we aimed to provide a microbiological basis for the management of chronic infections in this patient group.
A cross-sectional analysis was performed on samples from 24 patients (20 sputum, 4 BAL fluid). The study population was broadly reflective of the PCD population, with a range of ciliary phenotypes, ages, and severity of disease. Approximately half of the patients were receiving prophylactic antibiotics, and a similar proportion was receiving inhaled corticosteroids.
Comparison of culture-independent and culture-based analyses. The culture-based diagnostic microbiology data are shown in Table S4 in the supplemental material. In a number of instances where the recognized respiratory pathogens were reported by culture-based analysis, they were also found to have a high relative abundance in sequencing profiles. For example, P. aeruginosa was detected by culture in patients 5 and 15, representing 96.7 and 98.7 of the sequences, respectively. However, discrepancies were also observed. For example, in patient 16, P. aeruginosa represented 96.2% of sequences but was not reported by culture. Further, P. aeruginosa was detected in a further 8 patients at a low relative abundance but was not reported by diagnostic microbiology. Similar discrepancies were observed for H. influenzae and S. pneumoniae.
Determination of total bacterial load. The initial stage of culture-independent analysis involved an assessment of the bacterial density in the airway samples. Here, the total numbers of bacterial cells per unit volume of respiratory secretion were determined by qPCR. Bacterial loads ranged from 1.3 ϫ 10 4 to 5.2 ϫ 10 9 CFU/ml (mean Ϯ standard deviation [SD], 1.0 ϫ 10 9 Ϯ 1.7 ϫ 10 9 CFU/ml) and were significantly lower in BAL fluid samples than in sputum samples (mean Ϯ SD, 2.2 ϫ 10 6 Ϯ 4.8 ϫ 10 6 CFU/ml and 1.2 ϫ 10 9 Ϯ 1.8 ϫ10 9 CFU/ml, respectively; P ϭ 0.005). These bacterial cell densities are broadly consistent with those reported in other chronic respiratory bacterial infections, such as CF and non-CF bronchiectasis, as assessed using the same analytical approach (9, 17) .
The observed bacterial loads were positively correlated with patient age (P ϭ 0.002, Spearman's correlation). However, a significant correlation between age and lung function decline has been reported previously (6) but was not detected here. Intuitively, increasing bacterial load might be linked with increasing disease severity, and therefore the absence of a significant relationship between bacterial load and lung function in our study is perhaps surprising. However, longitudinal studies of PCD patients suggest that the courses of lung function vary greatly between patients (26), suggesting that larger studies are required to fully define this relationship.
Airway bacterial community composition. The types of bacteria present in the PCD airway samples were assessed by 16S rRNA gene pyrosequencing. A total of 311,996 sequences were derived from the sample collection. After stringent sequence curation, a total of 187,071 bacterial sequences were carried forward, representing an average of 7,482 sequences per sample (range, 902 to 17,586).
Across the sample collection, 128 separate genera were detected, with an average of 24 per sample (SD, 11.2; range, 5 to 57). Of these, 39 genera were detected only in one patient. The detected genera were predominantly from the phyla Firmicutes, Proteobacteria, Actinobacteria, and Bacteroidetes, representing 30.4%, 28.9%, 17.2%, and 9.4% of the sequences, respectively. The occupancy of the genera ranged from 1 to 21 patients, with a mean frequency of 4.9 patients (SD, 5.1). Those genera detected in Ն10 patients are listed in Table 2 . Bacterial diversity was assessed using three separate measures (richness, Shannon index, and Chao1) (see Fig. S1 in the supplemental material). However, no significant correlations were found between community diversity and clinical measures.
Given that complex microbial communities exist in the oropharynx and upper respiratory tract, and that there is the potential for bacteria to be introduced to the lower airways from the wider environment, the detection of a broad phylogenetic range of bacterial species was expected. However, the relative abundances of the detected genera varied greatly. The mean relative abundance of the "dominant genus" (the genus representing the greatest proportion of total sequence identities in each sample) was 64.5% of all detected sequences (SD, 24.5; range, 19.9 to 99.5%). However, many of the detected genera were present at a low relative abundance; when rank ordered according to relative abundance, typically, only the seven most prevalent genera in each patient contributed Ͼ1% of the total bacterial signal.
While the clinical significance of a particular bacterial taxon can be disproportionate to its relative abundance, in the lower airways, a context thought to be free from substantial bacterial colonization in healthy individuals, an argument can be made for focusing first on those bacteria that are greatest in number (Table  3 ). These dominant genera included both those likely to be reported through standard diagnostic microbiology (e.g., Pseudomonas, Haemophilus, and Streptococcus) and those unlikely to be detected without specific growth conditions being present (e.g., Prevotella). Further, the majority of genera detected in a high proportion of patients, or at a high relative abundance, were those commonly associated with the airways or oropharynx (Pseudomonas, Haemophilus, Streptococcus, Neisseria, Prevotella, Veillonella, Porphyromonas, and Actinomyces) or gastrointestinal tract or oral cavity (Blautia and Campylobacter). In a number of cases, however, genera that did not fall into either of these groups were also detected with a high relative abundance. For example, Ralstonia species were detected in 17 of the 24 patients (68%) by 16S rRNA gene sequencing analysis (see Table S5 in the supplemental material), with a mean relative abundance of 20.4% (SD, 31.9; range, 0.1% to 89.6%), and represented the dominant genus in four patients.
The high prevalence of Ralstonia in PCD airway secretions observed here warrants further consideration. While other nonfermenting Gram-negative bacilli, including P. aeruginosa, Acinetobacter baumannii, Stenotrophomonas maltophilia, and Burkholderia cepacia complex, have been recognized as common causes of respiratory infection, the role of Ralstonia species is less well understood. Some Ralstonia species have, however, previously been recovered from a range of infection contexts (27) , including the CF airway, most commonly from the species R. mannitolilytica, R. pickettii, and R. respiraculi (23) . Here, the relative abundance of Ralstonia species was significantly higher in BAL fluid samples than in sputum samples (P ϭ 0.01, one-way analysis of variance [ANOVA] ). Due to the unanticipated high incidence of the genus in the PCD samples analyzed here, genus-specific PCR was used to confirm the detection of Ralstonia species. A positive PCR result was obtained for 17 of the 18 respiratory sample extracts in which Ralstonia was detected by pyrosequencing and in a further three samples in which it was not (see Table S5 in the supplemental material). Species-specific PCR detected R. pickettii in 18 samples and R. mannitolilytica in two samples. R. respiraculi and R. insidiosa were not detected.
While not normally considered to be associated with virulence (27) (and not observed to be negatively correlated with lung function in this study), the clinical significance of the detection of Ralstonia species in PCD airway secretions remains to be determined. The previous occurrence of "pseudo-outbreaks" due to contaminated diagnostic reagents (27) means that the detection of Ralstonia species must be interpreted with some caution. However, the detection of more than one Ralstonia species within the patient group perhaps suggests this was not the case here.
The high abundance of the genus Blastococcus in one patient is also noteworthy. Members of this genus have been isolated from a range of environmental contexts (5), with the species detected here, Blastococcus aggregatus, associated with brackish water in particular (28) . The potential clinical significance of this species in the PCD airway is not yet known.
Correlations of species relative abundance and hierarchical cluster analysis. We investigated whether significant relationships existed between the relative abundance of different bacterial community members. A number of significant correlations were identified and are listed in Table 4 . Of particular note are the significant negative correlation between the relative abundances of Pseudomonas and Porphyromonas and the significant positive correlations between a number of anaerobic genera, including Prevotella, Neisseria, Porphyromonas, and Streptococcus. There are several potential explanations for the existence of these relationships. P. aeruginosa was present at a high relative abundance in a number of samples, and the predominance of a single member of the bacterial community in this way can result in a reduction of the relative abundances of other bacteria. However, in addition, these negative correlations may also reflect differences in airway conditions (particularly oxygen tension in the cases of anaerobic genera), the ecological interactions between different bacterial species, and the extent of the oropharyngeal contribution to sputum. The predominance of either Pseudomonas or a mixed group of facultative and obligate anaerobes has been reported in airway samples from other contexts, including in CF (16) .
Correlation of relative species abundance and clinical measures. Hierarchical cluster analysis was used to assess the extent to which bacterial community structure correlated with clinical measures. No clear relationships between patient data and community clustering were identified, although samples obtained by BAL tended to cluster within a broad subgroup, suggesting a more discrete composition compared to that for sputum samples (see Fig. S2 in the supplemental material) . A comparison of the composition of BAL fluid samples and sputum samples revealed that the former contained significantly lower numbers of bacterial cells (P ϭ 0.001, Wilcoxon rank sum test) and contained significantly higher relative levels of the genera Ralstonia, Corynebacterium, Staphylococcus, Anaerococcus, Propionibacterium, and Acinetobacter (P Ͻ 0.05). This divergence between sample types might reflect bacterial community differences across the airway regions, the contribution of oropharyngeal bacteria to expectorated sputum, and the younger age of patients sampled using this approach.
Both positive and negative significant correlations were identified between the relative abundances of particular genera and patient age, FEV 1 (percent predicted), and dominant genus relative abundance (used here as a marker of bacterial overgrowth) ( Table 5 ). In particular, there were significant positive correlations between P. aeruginosa relative abundance and both patient age and dominant genus abundance and significant negative correlations with FEV 1 (percent predicted). These findings are in line with the similar strong associations reported for Pseudomonas with disease progression across a range of obstructive airway diseases (6, 29, 30) . Further, P. aeruginosa infection has been shown to be associated with bronchiectasis and air trapping in PCD (31). Significant positive associations were observed between the genera Fusobacterium, Prevotella, Mycoplasma, Abiotrophia, and Selenomonas and the occurrence of sinusitis. Of these, only the association with Fusobacterium remained significant following continuity correction (P ϭ 0.014, Pearson's chi-square test). While members of this genus would be unlikely to be isolated by standard microbiological analysis of respiratory samples, they are commonly associated with sinus infections (32) .
Bacterial community temporal stability. Chronic infections of CF lower airways can vary relatively little in terms of bacterial community composition over periods of a year or more when patients are clinically stable (10, 33) . At the same time, the occurrence of exacerbations and the associated antibiotic therapies result in large-scale changes in community composition (34) . We therefore investigated whether a similar pattern also exists in PCD infections through the analysis of a limited number of follow-up samples.
First, analysis was performed on paired sputum samples, which were collected at the same hospital visit and obtained from three of the patients and used to assess intersample variation and technical reproducibility (Fig. 1) . Bray-Curtis similarity scores were used to determine similarities between the paired samples. Scores of 0.93, 0.85, and 0.53 were obtained from the three sample pairs, respectively, compared to 0.19 between the samples from all patients. Bacterial community temporal stability was then assessed through the analysis of follow-up samples obtained from four patients in the study (Fig. 2) . In three cases, both sample points were obtained during times of stability, and in one case, the follow-up sample was obtained during a period of exacerbation. Stable follow-up samples showed a high level of community stability, even where the interval period between samples was Ͼ3.5 years (Bray-Curtis similarity score, 0.9). However, when the second sample was obtained during exacerbation, community similarity was greatly reduced (Bray-Curtis similarity score, 0.32) despite an intervening period of only 87 days. While based on only a small group of patients, these longitudinal observations suggest that bacterial community composition typically varies substantially between individual patients but can remain remarkably stable for given patients over long periods.
The relatively small size of the patient groups from whom sam- ples were obtained represents a limitation of our study; this in part reflects the rarity of PCD. The application of the analysis described here to a larger patient population would present an opportunity to compare the airway microbiology of PCD patients with that of patients with other chronic lower respiratory infections, such as CF and non-CF bronchiectasis. Such comparative analyses might aid in the delineation of relationships between bacterial community composition and airway characteristics, such as airway stasis in the case of PCD. As such, this represents an important area for future investigation. In addition, the study described here was primarily cross-sectional; more detailed longitudinal analyses are also likely to provide important additional insights into the relationships between bacterial community dynamics and disease progression.
In conclusion, in providing an in-depth culture-independent analysis of PCD lower airway microbiology, we highlight the potential contributions of species that are unlikely to be isolated through conventional diagnostic microbiology to disease progression. The data presented here provide insight into the processes that take place in a respiratory system when bacterial clearance is compromised, with relationships between bacterial community composition and clinical measures of disease identified. These findings and their implications for treatment now warrant further investigation.
